SurModics Ownership
| SRDX Stock | USD 39.56 0.23 0.58% |
Shares in Circulation | First Issued 2009-03-31 | Previous Quarter 14 M | Current Value 14 M | Avarage Shares Outstanding 14.6 M | Quarterly Volatility 1.6 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
SurModics |
SurModics Stock Ownership Analysis
About 83.0% of the company shares are owned by institutional investors. The book value of SurModics was at this time reported as 8.38. The company recorded a loss per share of 0.82. SurModics had not issued any dividends in recent years. The entity had 2:1 split on the 7th of December 2000. Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota. Surmodics operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 389 people. To find out more about SurModics contact Gary Maharaj at 952 500 7000 or learn more at https://www.surmodics.com.Besides selling stocks to institutional investors, SurModics also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different SurModics' stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align SurModics' strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
SurModics Quarterly Liabilities And Stockholders Equity |
|
SurModics Insider Trades History
Roughly 4.0% of SurModics are currently held by insiders. Unlike SurModics' institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against SurModics' private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of SurModics' insider trades
SurModics Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as SurModics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading SurModics backward and forwards among themselves. SurModics' institutional investor refers to the entity that pools money to purchase SurModics' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Alliancebernstein L.p. | 2024-06-30 | 290.8 K | Disciplined Growth Investors Inc | 2024-09-30 | 276.9 K | Gardner Lewis Asset Management L P | 2024-09-30 | 212.9 K | Goldman Sachs Group Inc | 2024-06-30 | 167.1 K | Capula Management Ltd | 2024-06-30 | 165.1 K | Gamco Investors, Inc. Et Al | 2024-09-30 | 146.4 K | Eisler Capital (uk) Ltd. | 2024-09-30 | 136.4 K | Northern Trust Corp | 2024-09-30 | 129.3 K | Cnh Partners, Llc | 2024-06-30 | 123 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 2.2 M | Beryl Capital Management Llc | 2024-06-30 | 1.5 M |
SurModics Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific SurModics insiders, such as employees or executives, is commonly permitted as long as it does not rely on SurModics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases SurModics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
SurModics Outstanding Bonds
SurModics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. SurModics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most SurModics bonds can be classified according to their maturity, which is the date when SurModics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View |
SurModics Corporate Filings
10K | 20th of November 2024 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
| 15th of November 2024 Other Reports | ViewVerify | |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
8K | 6th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for SurModics Stock Analysis
When running SurModics' price analysis, check to measure SurModics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SurModics is operating at the current time. Most of SurModics' value examination focuses on studying past and present price action to predict the probability of SurModics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SurModics' price. Additionally, you may evaluate how the addition of SurModics to your portfolios can decrease your overall portfolio volatility.